Article
Total Lesion Glycolysis in Positron Emission Tomography Can Predict Gefitinib Outcomes in Non-Small-Cell Lung Cancer with Activating EGFR Mutation.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer - 1 Aug 2015
Keam Bhumsuk, Lee Soo Jin, Kim Tae Min, Paeng Jin Chul, Lee Se-Hoon, Kim Dong-Wan, Jeon Yoon Kyung, Chung Doo Hyun, Kang Keon Wook, Chung June-Key, Heo Dae Seog
Abstract excerpt
INTRODUCTION: The purpose of this study was to evaluate the predictive role of quantitative metabolic parameters using total lesion glycolysis (TLG) in F-2-fluoro-2-deoxyglucose-positron emission tomography/computed tomography for developing gefitinib resistance in epidermal growth factor receptor (EGFR)-mutant non-small-cell lung cancer (NSCLC) patients treated with first-line gefitinib. METHODS: A total of 75...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
